Akademik Veri Yönetim Sistemi
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.7, sa.2, ss.29-36, 2010 (ESCI)
In a pregnant diabetic patient, excellent glucose control is neccessary for well-being of the mother and the fetus. Insulin therapy is the first choice in cases where diet and excersise treatment failed to achieve desired glucose levels. The rationale for insulin therapy is based on mimicking the physiology of insulin secretion. The rapid acting insulin analogues (aspart, lispro) and medium acting insulin, NPH, are the first choice for insulin therapy during pregnancy. Patients should learn how to inject their own insulin and to monitor their blood glucose levels.